Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks

Novavax, Inc. (NVAX) reported a fourth-quarter 2023 loss of $1.44 cents per share, much wider than the Zacks Consensus Estimate of a loss of 49 cents. In the year-ago quarter, the company reported a loss of $2.28 per share.Revenues in the quarter amounted to $291.3 million, also missing the Zacks Consensus Estimate of $334.0 million. The top line declined 18.5% on a year-over-year basis.Quarter in DetailIn the reported quarter, the company recorded $251.4 million in product sales, reflecting a decrease of 1 ...